BROOKLYN IMMUNOTHERAPEUTICS's ticker is BTX and the CUSIP is 114082100. A total of 39 filers reported holding BROOKLYN IMMUNOTHERAPEUTICS in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $0 | – | 17 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| LAKE STREET ADVISORS GROUP, LLC | 2,446,417 | $604,000 | 0.04% |
| INVERNESS COUNSEL LLC /NY/ | 1,210,537 | $299,000 | 0.02% |
| Sippican Capital Advisors | 37,500 | $9,000 | 0.01% |
| ARMISTICE CAPITAL, LLC | 1,109,807 | $274,000 | 0.01% |
| Virtu Financial LLC | 63,122 | $16,000 | 0.00% |
| Renaissance Technologies | 1,459,626 | $360,000 | 0.00% |
| Allegheny Financial Group LTD | 11,595 | $2,000 | 0.00% |
| AJ WEALTH STRATEGIES, LLC | 36,001 | $9,000 | 0.00% |
| BALDWIN BROTHERS LLC/MA | 40,604 | $10,000 | 0.00% |
| FMR LLC | 36 | $0 | 0.00% |